This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationDispense.
Generated Narrative: MedicationDispense
Resource MedicationDispense "meddisp0322"
status: completed
- | Concept |
* | Dilantin 125mg/5ml Oral Suspension (National drug codes#0071-2214-20) |
subject: Patient/pat1: Donald Duck "Donald DUCK"
- | Actor |
* | Practitioner/f006 "Rob VAN DEN BERK" |
authorizingPrescription: MedicationRequest/medrx0312
type: Refill - Part Fill (ActCode#RFP)
quantity: 360 ml (Details: UCUM code ml = 'ml')
daysSupply: 30 Day (Details: UCUM code d = 'd')
whenPrepared: 2015-01-16T07:13:00+05:00
whenHandedOver: 2015-01-18T07:13:00+05:00
dosageInstruction
sequence: 1
text: 100mg (4ml) three times daily
timing: 3 per 1 days
route: Oral Route (qualifier value) (SNOMED CT#26643006)
doseAndRate
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.